Rasagiline in Parkinson's disease: a review based on meta-analysis of clinical data.

Author: JordánJoaquín, Mínguez-MínguezSara, Solís-García Del PozoJulián

Paper Details 
Original Abstract of the Article :
Rasagiline (Azilect(®)) is a selective and irreversible monoamine oxidase B inhibitor, which is well tolerated, safe, improves motor symptoms, and prevents motor complications in Parkinson's disease (PD). Rasagiline is effective in monotherapy and as an adjunct to levodopa-therapy, with beneficial e...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.phrs.2013.05.005

データ提供:米国国立医学図書館(NLM)

Rasagiline: A Glimmer of Hope in the Desert of Parkinson's Disease

We're exploring the desert of Parkinson's disease, a neurodegenerative condition that affects movement. This study investigated the effectiveness of rasagiline, a drug that inhibits monoamine oxidase B, in treating Parkinson's. Researchers conducted a meta-analysis of clinical trials to evaluate the efficacy of rasagiline. They found that rasagiline, when used alone or in combination with levodopa, improved motor symptoms in patients with Parkinson's. This finding is like discovering a glimmer of hope in the vast desert of Parkinson's, offering a potential path towards better symptom management.

Navigating the Desert: Rasagiline's Potential for Parkinson's Management

This study suggests that rasagiline might provide relief from motor symptoms in patients with Parkinson's disease. This finding is like discovering a hidden spring in the desert, offering a potential source of comfort and improved quality of life for those living with this challenging condition.

Navigating the Desert: The Importance of Research and Treatment Options

The desert of Parkinson's research is vast, and we need to continue exploring new and innovative treatment options. This study serves as a reminder that with perseverance and dedication, we can find new paths towards better management of this debilitating disease.

Dr.Camel's Conclusion

This meta-analysis suggests that rasagiline might be a useful tool in the management of Parkinson's disease. It's a reminder that we must continue to seek new solutions and innovate to improve the lives of those battling this challenging condition. As a wise camel, I understand that the journey through the desert of Parkinson's can be long and arduous, but with hope, perseverance, and the right tools, we can find a path towards a better future.

Date :
  1. Date Completed 2014-03-05
  2. Date Revised 2015-08-31
Further Info :

Pubmed ID

23735235

DOI: Digital Object Identifier

10.1016/j.phrs.2013.05.005

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.